Address And Details

82 Devonshire St , Boston, MA 02109
Fund Manager Brett Sumsion
Manager Tenure 4 Years 4 Months

Strategy And Objective

The fund seeks high total return with a secondary objective of principal preservation as the fund approaches its target date and beyond. Investing primarily in a combination of Fidelity® domestic equity funds,international equity funds,bond funds,and short-term funds (underlying Fidelity® funds).Allocating assets according to a neutral asset allocation strategy shown in the glide path below that adjusts over time until itreaches an allocation similar to that of the Fidelity Advisor Freedom® Income Fund,approximately 10 to 19 years after theyear 2030.Fidelity Management & Research Company LLC (the Adviser) may modify the fund’s neutral asset allocationsfrom time to time when in the interests of shareholders.Buying and selling futures contracts (both long and short positions) in an effort to manage cash flows efficiently, remain fully invested,or facilitate asset allocation.The neutral asset allocation shown in the glide path depicts the allocation to domestic equity funds,international equity funds,bond funds (including investment grade debt,inflation-protected debt,and long-term treasury debt),and short-term funds.The Adviser,under normal market conditions, will make investments that are consistent with seeking high total return forseveral years beyond the fund's target retirement date in an effort to achieve the fund's overall investment objective.

Net Asset Value

as of 5:16 PM ET 10/18/2021

Performance

  • 1 Week
  • +1.90%
  • 1 Month
  • +0.49%
  • 3 Months
  • +2.25%
  • 1 Yr Return
  • +11.77%
  • 5 Yr Return
  • n/a

Equity Sector Breakdown

Finance 97.64%
ConsumerDurables n/a
Energy n/a
Health n/a
IndustrialCyclical n/a
NonDurables n/a
RetailTrade n/a
Services n/a
Technology n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Other 97.64%
Stocks 2.37%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
ForeignStocks 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 5.15 B

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -0.12 n/a n/a
Beta 0.69 n/a n/a
R Squared 0.93 n/a n/a
Std Deviation 13.44 n/a n/a
Sharpe Ratio 0.83 n/a n/a

Purchase Information

as of 5:26 PM ET 10/15/2021
Minimum Initial $0
Minimum Additional $0
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 09/30/2021 Average Annual Current Performance Quarterly As Of 09/30/2021 Avg Annual Current Performance Monthly As Of 09/30/2021 Avg Annual Current Performance Quarterly As Of 09/30/2021
1 Year
  • +21.40%
  • +21.40%
+21.40% +21.40%
3 Year
  • +11.32%
  • +11.32%
+11.32% +11.32%
10 Year
  • n/a
  • n/a
n/a n/a
Life Of Fund
  • +10.67%
  • +10.67%
+10.67% +10.67%

Top 10 Holdings

Symbol Company Name % Of Assets
FSIPX FIDELITY SER INFL PR BOND ID 5.65%
FDMLX FIDELITY SER INTRINSIC OPP FD 5.50%
FCGSX FIDELITY SER GROWTH COMPANY F 5.32%
FIGSX FIDELITY SER INTL GROWTH FD 4.99%
FSOSX FIDELITY SER OVERSEAS FUND 4.98%
FINVX FIDELITY SER INTL VALUE FD 4.97%
FGLGX FIDELITY SER GROWTH & INCOME 4.79%
FBLEX FIDELITY SER ST SEL LG CP VAL 4.06%
FNKLX FIDELITY SER VALUE DISCOVERY 3.12%
FSIGX FIDELITY SERIES INV GRADE BD 21.01%

Recent Articles from TheStreet

What to Watch Tuesday: Procter & Gamble Earnings, Inflation Data

Premarket Movers Tuesday - Procter & Gamble, Ulta, Netflix

Stocks moving in premarket trading include Procter & Gamble. Ulta, Netflix, Johnson & Johnson and Teladoc.

After Red-hot IPO, Chinese Biotech Firm Kintor Eyes Blockbuster Drugs For Prostate Cancer, Sex Hormone-related Hair Loss

Atea Pharma Stock Plunges After COVID Treatment Trial Disappoints; Merck Jumps

Atea Pharmaceuticals could shed more than $2 billion in value Tuesday after the drugmaker said a mid-stage trial of its developing COVID treatment failed to meet expectations.

What to know about Cloudflare's Upcoming IPO

Investing in the Cloud: Consider Cloudflare and Digital Ocean

Cloud-software growth stocks have been a bright spot in an uncertain market. Investors might look closely at Cloudflare and Digital Ocean.

Philip Morris International Lead

Philip Morris Ekes Out Third-Quarter Earnings Beat

Philip Morris posts a third-quarter earnings beat as sales of its smokeless non-tobacco products continue strong, though cautions on supply chain impact.

The Travelers Companies Lead

Travelers Posts Third Quarter Earnings Beat on Record Net Written Premiums

Travelers Companies posts third-quarter earnings that exceed analysts’ forecasts as a drop in what it calls ‘catastrophic losses’ offsets record net written premiums.

Lufax is set to make the biggest splash on the NYSE by a Chinese company since e-commerce giant Alibaba's IPO in 2014. Photo: Reuters

Stock Market Today: Dow Gains On Earnings Strength; Housing Starts Disappoint

Solid third quarters continue to power stocks higher Tuesday, even as growth and inflation signals remain stubbornly persistent as oil prices top $85 a barrel in overnight trading.

Procter & Gamble Is Under Siege From an Activist Investor

Procter & Gamble Stock Slips After Q1 Earnings Beat; 2022 Forecast Unchanged

Procter & Gamble held its 2022 forecasts in place, seeing sales growth of between 2% and 4%, following stronger-than-expected first quarter earnings.

No More Tears for Johnson & Johnson?

Johnson & Johnson Stock Gains as Vaccine Sales Boost Q3 Earnings, 2021 Forecasts

Johnson & Johnson said it sees 2021 vaccine sales of $2.5 billion, with overall revenues rising to between $94.1 billion to $94.6 billion, following its Q3 earnings beat.

Stock Market Lead

Stocks Gain, SEC GameStop Report, Rent The Runway IPO - 5 Things You Must Know

Stocks edge higher ahead of earnings; SEC says GameStop surge powered by believers; FDA set to approve "mix & match' COVID boosters; DraftKings faces Entain bid deadline and Rent the Runway seeks $1.3 billion valuation in Nasdaq IPO.